Department of Breast Surgery, National Cancer Center Hospital, Tokyo, Japan.
Department of Breast Surgery, National Cancer Center Hospital, Tokyo, Japan.
Clin Breast Cancer. 2021 Aug;21(4):e302-e311. doi: 10.1016/j.clbc.2020.11.008. Epub 2020 Nov 17.
It has been determined that axillary lymph node dissection after the detection of limited axillary lymph node metastasis does not improve the prognosis of patients with breast cancer. Thus, a need exists for less-invasive axillary surgery. However, it remains unclear whether a predictive model based on preoperative data would be sufficient to accurately predict the probability of pN2-N3 (> 3 lymph node metastases). We sought to develop an easy-to-use scoring system to distinguish between pN0-N1 (0-3 lymph node metastases) and pN2-N3 using only preoperative data and validate its predictive performance.
We retrospectively identified 2687 patients diagnosed with cT1-3cN0-N1 who had undergone surgery in our hospital from 2013 to 2019. We evaluated the risk factors associated with pN2-N3 by logistic regression analysis and developed a scoring system. Predictive performance was assessed by calculating the receiver operating characteristic area under the curve (AUC) and was validated using K-fold cross-validation.
We identified 1987 patients with stage pN0, 522 with pN1, and 178 with pN2-N3. Multivariate analysis revealed tumor size, number of suspicious lymph nodes on axillary ultrasound examination, histologic type, histologic grade, and receptor status were significant risk factors for pN2-N3. The AUC value was 0.87, and the mean AUC of the 10-fold cross-validation was 0.88. When the cutoff score was set at 6, the negative predictive value for excluding patients with pN2-N3 was 98.4%.
Our easy-to-use scoring system could be useful to preoperatively identify patients at lower risk of pN2-N3 and avoid unnecessary axillary lymph node dissection.
已经确定,在检测到腋窝淋巴结有限转移后进行腋窝淋巴结清扫并不能改善乳腺癌患者的预后。因此,需要进行创伤更小的腋窝手术。然而,目前尚不清楚是否可以基于术前数据建立一个预测模型来准确预测 pN2-N3(>3 个淋巴结转移)的概率。我们试图开发一种易于使用的评分系统,仅使用术前数据即可区分 pN0-N1(0-3 个淋巴结转移)和 pN2-N3,并验证其预测性能。
我们回顾性地确定了 2687 名在我院于 2013 年至 2019 年间接受手术治疗的 cT1-3cN0-N1 期患者。我们通过逻辑回归分析评估了与 pN2-N3 相关的风险因素,并开发了一个评分系统。通过计算受试者工作特征曲线下的面积(AUC)评估预测性能,并使用 K 折交叉验证进行验证。
我们确定了 1987 名 pN0 期患者、522 名 pN1 期患者和 178 名 pN2-N3 期患者。多变量分析显示肿瘤大小、腋窝超声检查可疑淋巴结数量、组织学类型、组织学分级和受体状态是 pN2-N3 的显著危险因素。AUC 值为 0.87,10 折交叉验证的平均 AUC 值为 0.88。当截断分数设定为 6 分时,排除 pN2-N3 患者的阴性预测值为 98.4%。
我们易于使用的评分系统可用于术前识别 pN2-N3 风险较低的患者,避免不必要的腋窝淋巴结清扫。